Flavonoids from Salvia chloroleuca with α-Amylsae and α-Glucosidase Inhibitory Effect

被引:2
作者
Asghari, Behvar [1 ,2 ]
Salehi, Peyman [2 ]
Sonboli, Ali [3 ]
Ebrahimi, Samad Nejad [2 ,4 ]
机构
[1] Imam Khomeini Int Univ, Fac Engn & Technol, Dept Plant Prod & Breeding, Qazvin, Iran
[2] Shahid Beheshti Univ, Med Plants & Drugs Res Inst, Dept Phytochem, GC, Tehran, Iran
[3] Shahid Beheshti Univ, Med Plants & Drugs Res Inst, Dept Biol, GC, Tehran, Iran
[4] Univ Basel, Div Pharmaceut Biol, CH-4056 Basel, Switzerland
来源
IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH | 2015年 / 14卷 / 02期
关键词
Salvia chloroleuca; alpha-amylase; alpha-glucosidase; Enzyme inhibition; Flavonoids; AMYLASE; GLYCOSIDES; CONSTITUENTS;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
It is believed that the inhibition of carbohydrate hydrolyzing enzymes including alpha-amylase and alpha-glucosidase is one of the therapeutic approaches to decrease the postprandial glucose level after a meal, especially in the people with type 2 diabetes. Medicinal plants and their extracts are one of the main sources to find new inhibitors to the enzymes. In our study four flavonoids, namely luteolin 7-O-glucoside (1), luteolin 7-O-glucuronide(2), diosmetin 7-O-glucuronide (3) and salvigenin (4) were isolated from aerial parts of Salvia chloroleuca. The inhibitory activity of these compounds against alpha-amylase and alpha-glucosidase were evaluated. Compounds 1, 2 and 3 showed potent alpha-glucosidase inhibitory effect with IC50 values of 18.3, 14.7, and 17.1 mu M, respectively. Also these compounds exhibited moderate alpha-amylase activity with IC50 values 81.7, 61.5, and 76.3 mu M, respectively.
引用
收藏
页码:609 / 615
页数:7
相关论文
共 25 条
[1]  
[Anonymous], 2002, WHO TRAD MED STRAT
[2]  
Ayatollahi SA, 2009, IRAN J PHARM RES, V8, P179
[3]  
BISCHOFF H, 1994, EUR J CLIN INVEST, V24, P3
[4]   Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence [J].
Boyle, James P. ;
Thompson, Theodore J. ;
Gregg, Edward W. ;
Barker, Lawrence E. ;
Williamson, David F. .
POPULATION HEALTH METRICS, 2010, 8
[5]  
de Sales PM, 2012, J PHARM PHARM SCI, V15, P141
[6]   Inhibitory potential of trilobatin from Lithocarpus polystachyus Rehd against α-glucosidase and α-amylase linked to type 2 diabetes [J].
Dong, Hua-Qiang ;
Li, Mei ;
Zhu, Feng ;
Liu, Fu-Lai ;
Huang, Jian-Bo .
FOOD CHEMISTRY, 2012, 130 (02) :261-266
[7]   Triterpenoids with Rare Carbon Skeletons from Salvia hydrangea: Antiprotozoal Activity and Absolute Configurations [J].
Farimani, M. Moridi ;
Bahadori, M. Babak ;
Taheri, Salman ;
Ebrahimi, Samad N. ;
Zimmermann, Stefanie ;
Brun, Reto ;
Amin, Gholamreza ;
Hamburger, Matthias .
JOURNAL OF NATURAL PRODUCTS, 2011, 74 (10) :2200-2205
[8]   Antidiabetic Activity of Gnidia glauca and Dioscorea bulbifera: Potent Amylase and Glucosidase Inhibitors [J].
Ghosh, Sougata ;
Ahire, Mehul ;
Patil, Sumersing ;
Jabgunde, Amit ;
Dusane, Meenakshi Bhat ;
Joshi, Bimba N. ;
Pardesi, Karishma ;
Jachak, Sanjay ;
Dhavale, Dilip D. ;
Chopade, Balu A. .
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2012, 2012 :1-10
[9]  
Gohari AR, 2011, IRAN J PHARM RES, V10, P247
[10]  
HERMANS MMP, 1991, J BIOL CHEM, V266, P13507